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Sickle cell anemia (SCA) is a hereditary hemoglobinopathy
caused by homozygosity for sickle hemoglobin (Hb S). Hb S is
caused by a single mutation in the -globin gene (HBB, glu6val)
resulting in the presence of valine instead of glutamic acid in
the sixth position of the -globin chain.1,2 Hb S can form poly-
mers when deoxygenated leading to vaso-occlusion and tissue
ischemia which may result in severe pain of the chest, back,
abdomen, or extremities.2,3
Acute chest syndrome (ACS) is an acute illness character-
ized by fever and/or respiratory symptoms, accompanied by
new pulmonary inﬁltrates on a chest X-ray. 4–10 It is the leading
cause of hospitalization and intensive care unit admission,4,6
as well as the most common cause of death in adult patients
8,9with SCA even among those on hydroxyurea (HU) therapy.
Factors such as infection, fat embolism, iatrogenic ﬂuid over-
load, hypoventilation from pain or narcotic analgesics, and
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reserved.vaso-occlusion of the pulmonary vasculature contribute to the
pathogenesis of ACS.1,2,7 Neurologic complications following
ACS occur in about 22% of adults and 8% of children with
SCA.10 The pathophysiology of neurological deﬁcits in patients
with ACS seems to be related to an abrupt decrease in oxy-
genation in the vascular bed of the central nervous system.
Acute ischemic stroke (AIS) is a devastating neurological
complication of SCA, occurring in about 8% of Hb SS children
by their second decade of life. Children with SCA and strokes
frequently present with vasculopathy in the distal internal
carotid and middle cerebral arteries, although extracranial
vasculopathy can also be present.2 Other less common neu-
rologic complications of SCA include hemorrhagic stroke,
transient ischemic attack, silent cerebral infarct, dural venous
sinus thrombosis, posterior reversible encephalopathy syn-
drome (PRES), and migraine.5,11,12SP, Escola Paulista de Medicina, R Dr Diogo de Faria, 825, Vila
Although occlusion of cervical carotid arteries is a known
cause of AIS, these vessels are not routinely screened in
sickle cell disease. These patients are commonly examined
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Figure 1 – Brain magnetic resonance image showing
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Figure 2 – Computed tomography angiography with partial
and total obstruction of the left and right cervical carotidequelae in the right temporal region.
ith neurological imaging such as magnetic resonance imag-
ng (MRI); magnetic resonance angiography and transcranial
oppler sonography (TCD). However, these exams are mainly
arried out to identify lesions in the major intracerebral
essels.12
We  report a case of an adult SCA patient who presented
ith ACS followed by cardiac arrest and coma due to cerebral
ypoperfusion.
ase  report
 23-year-old female with SCA and a past medical history
f two  episodes of ischemic stroke was admitted to hospi-
al due to fever, tachypnea, thoracic pain, hypoxemia, cough
nd wheezing. She had been on chronic blood transfusions
or 14 years since her ﬁrst stroke and had also been taking
ydroxyurea for two years. This strategy was chosen due to
he difﬁculty in maintaining the ideal interval between trans-
usions as a result of alloimmunization.
Auscultation of the chest revealed reduced breath sounds
t the left pulmonary base. A chest X-ray showed a left
ower lobe inﬁltrate and the oxygen saturation was 95% with
 continuous positive airway pressure using 50% oxygen.
espite treatment for ACS (supportive care, ﬂuid manage-
ent, oxygenation, chest physiotherapy and antibiotics), two
ays after hospital admission the patient suffered cardio-
espiratory arrest. After a successful resuscitation, although
he responded to pain, she had no spontaneous eye opening
nd no verbal response. She also had bilateral deviation of eye
ovement  to the right, but no other clinical signs of meningeal
rritation. The diagnosis of coma (Glasgow Coma Score 5) was
ubsequently made.
Brain magnetic resonance imaging after the cardiac arrest
howed only old ischemic areas compatible with her previous
trokes (Figure 1). A computerized tomography angiography
evealed severe stenosis of the left cervical internal carotid
rtery and occlusion of the right cervical internal carotid
rtery (Figure 2). TCD showed symmetric but decreased bloodarteries.
ﬂow velocities in both middle cerebral arteries (time-averaged
maximum mean velocity: 40 cm/s), as well as collateral ﬂow
from the posterior circulation.
She remained in coma for 19 days and during this period
she was treated with multiple exchange blood transfusions
in order to maintain the Hb S concentration at <30%. She had
full neurological recovery without new deﬁcits (Glasgow Coma
Score 15). She has been followed up and treated with chronic
blood transfusions and acetylsalicylate (aspirin) for the last
three years.
Discussion
We  describe a patient with SCA who presented with ACS com-
plicated by cardiac arrest and coma. Despite having bilateral
cervical carotid artery disease, the patient had full neurologi-
cal recovery. In patients resuscitated from cardiac arrest, the
neurological outcome depends on immediate restoration of
systemic circulation and oxygenation to meet the cerebral
oxygen demand.13 In our patient, cerebral ﬂow was proba-
bly even more  compromised during cardiac arrest because of
bilateral cervical carotid artery disease.
Although there are several reports of ischemic stroke asso-
ciated with lesions in the cervical internal carotid artery
detected at autopsy by digital subtraction angiography and
by magnetic resonance angiography, most patients with SCA
and stroke are not screened for cervical artery disease, and
neuroimaging is usually restricted to the major intracere-
bral vessels.14–17 Our patient had had two previous strokes,
oter.
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however we  did not have an evaluation of her intracranial
vasculature before the cardiac arrest.
Collateral circulation can develop in patients with intracra-
nial and cervical artery occlusions. For instance, major
collateral anastomoses can occur between the ophthalmic
branch of the internal carotid artery and the terminal twigs of
the internal and external maxillary tributaries of the external
carotid arteries. Adequate collateral vessels confer protection
in the event of ischemic lesions.16 Our patient had low cere-
bral blood ﬂow velocities in the anterior circulation with robust
collateral ﬂow through the posterior circulation. Her excellent
neurological outcome was probably related to the presence of
posterior circulation collateral vessels.
The management of symptomatic cervical carotid artery
disease in patients without SCA is well established, with
revascularization being the gold standard treatment.18–20 In
patients with SCA and cervical carotid artery disease, the
impact of therapies such as endarterectomy or angioplasty
with stenting is uncertain. Rather, patients continue to be
managed with chronic blood transfusions similar to those
with intracranial carotid artery disease.
In conclusion, a good neurological outcome in patients
with bilateral cervical carotid artery disease is possible even in
the setting of extremely low cerebral blood ﬂow as seen during
cardiac arrest. The role of collateral circulation between extra-
and intra-cranial vessels in patients with SCA needs further
evaluation since this could inﬂuence the decision to consider
revascularization therapies in patients with cervical artery
disease. Also, the value of cervical carotid artery Doppler ultra-
sound scanning should be studied prospectively, since this
quick and non-invasive procedure may identify patients at
increased risk of stroke who  would otherwise be misdiagnosed
as PRES or several other differential diagnosis of SCA patients
with acute neurologic manifestations.
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